In the last trading session, 1.35 million Integra Lifesciences Holdings Corp (NASDAQ:IART) shares changed hands as the company’s beta touched 1.15. With the company’s per share price at $13.25 changed hands at $0.98 or 7.99% during last session, the market valuation stood at $1.03B. IART’s last price was a discount, traded about -146.49% off its 52-week high of $32.66. The share price had its 52-week low at $11.06, which suggests the last value was 16.53% up since then. When we look at Integra Lifesciences Holdings Corp’s average trading volume, we note the 10-day average is 1.48 million shares, with the 3-month average coming to 1.24 million.
Analysts gave the Integra Lifesciences Holdings Corp (IART) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.08. If we narrow down to specifics, the data shows that 1 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended IART as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
Integra Lifesciences Holdings Corp (NASDAQ:IART) trade information
Instantly IART was in green as seen at the end of in last trading. With action 11.63%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -53.91%, with the 5-day performance at 11.63% in the green. However, in the 30-day time frame, Integra Lifesciences Holdings Corp (NASDAQ:IART) is 4.66% up. Looking at the short shares, we see there were 6.12 million shares sold at short interest cover period of 5.09 days.
The consensus price target for the stock as assigned by Wall Street analysts is 33, meaning bulls need an upside of 59.85% from its current market value. According to analyst projections, IART’s forecast low is 20 with 86 as the target high. To hit the forecast high, the stock’s price needs a -549.06% plunge from its current level, while the stock would need to soar -50.94% for it to hit the projected low.
The 2025 estimates are for Integra Lifesciences Holdings Corp earnings to decrease by -12.52%, but the outlook for the next 5-year period is at 2.70% per year.
IART Dividends
Integra Lifesciences Holdings Corp is expected to release its next quarterly earnings report on 2025-May-05.
Integra Lifesciences Holdings Corp (NASDAQ:IART)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 14.22% of Integra Lifesciences Holdings Corp shares while 96.47% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 112.47%. There are 96.47% institutions holding the Integra Lifesciences Holdings Corp stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 14.5376% of the shares, roughly 11.25 million IART shares worth $327.92 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 10.0412% or 7.77 million shares worth $226.5 million as of 2024-06-30.
